Skip to main content
SpringerLink
Log in

Intracellular Infections of the Respiratory Tract

  • Published:
Drug Investigation Aims and scope Submit manuscript

Summary

Intracellular pathogens are phagocytosed microorganisms that retain their pathogenic activity. Thus, antimicrobial treatment must provide sufficient intracellular drug concentrations within the phagocyte to be effective. Respiratory tract infections, such as atypical pneumonias, can be a result of organisms capable of survival and reproduction even within alveolar macrophages; antimicrobial therapy should, therefore, consist of agents with the ability to accumulate intracellularly.

Macrolides are effective treatment for atypical pneumonias in that they show excellent intracellular penetration. Among the macrolides, roxithromycin features a broad spectrum of activity and an improved pharmacokinetic profile compared with erythromycin. In addition, roxithromycin accumulates to a greater extent intracellularly and subcellularly than erythromycin. Thus, roxithromycin may provide an improved therapeutic outcome in the treatment of these infections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Anderson R, van Rensburg CEJ, Joone G, Lukey PT. An in-vitro comparison of the intraphagocytic bioactivity of erythromycin and rox-ithromycin. Journal of Antimicrobial Chemotherapy 20(Suppl. B): 57–68, 1987

    PubMed  Google Scholar 

  • Anon. Antibiotics for communtiy-acquired pneumonia in adults. Drug and Therapeutics Bulletin 26: 13–16, 1988

  • Astarloa L, Maglio F, Cangelosi D, Garcia-Messina O. Roxithromycin in the treatment of atypical pneumonia in adult patients. British Journal of Clinical Practice 42(Suppl. 55): 94–95, 1988

    Google Scholar 

  • Bryskier A, Chantot JF, Lasc JC. Classification and structureactivity relationships of macrolides with emphasis on new developments. In Butzler & Kobayashi (Eds) Macrolides: a review with an outlook on future developments, pp. 7–21, Excerpta Medica, Amsterdam, 1986

    Google Scholar 

  • Carlier MB, Zenebergh A, Tulkens PM. Cellular uptake and subcellular distribution of roxithromycin and erythromycin in phagocytic cells. Journal of Antimicrobial Chemotherapy 20(Suppl. B): 47–56, 1987

    PubMed  CAS  Google Scholar 

  • Carlone NA, Ciuffini AM, Tullio V, Sassella D. Uptake of roxithromycin by mouse peritoneal macrophages. In Berkada & Kuemmerle (Eds) Progress in chemotherapy. Proceedings of the 15th International Congress of Chemotherapy, Istanbul, 19–24 July, 1987. Antimicrobial Section, Vol. 1, pp. 506–508, Ecomed, Landsberg, 1987

    Google Scholar 

  • Dette GA, Knothe H. Kinetics of erythromycin uptake and release by human lymphocytes and polymorphonuclear leucocytes. Journal of Antimicrobial Chemotherapy 18: 73–82, 1986

    Article  PubMed  CAS  Google Scholar 

  • Donowitz GR, Mandell GL. Acute pneumonia. In Mandell GL, et al. (Eds) Principles and practice of infectious diseases. 3rd ed., pp. 540–555, Churchill-Livingstone, New York, 1990

    Google Scholar 

  • Fernandez-MacLoughlin GJ, Lanoel JL, Stamboulian D, Savachian B. Roxithromycin in the treatment of atypical pneumonia. British Journal of Clinical Practice 42(Suppl. 55): 92–93, 1988

    Google Scholar 

  • Finch R. Treatment of respiratory tract infections with cephalosporin antibiotics. Drugs 34(Suppl. 2): 180–204, 1987

    Article  PubMed  Google Scholar 

  • Green GM, Jakab GJ, Low RB, Davis GS. Defense mechanisms of the respiratory membrane. American Review of Respiratory Dieases 115: 479–514, 1977

    CAS  Google Scholar 

  • Herron JM. Roxithromycin in the therapy of Streptococcus pyogenes throat infections. Journal of Antimicrobial Chemotherapy 20(Suppl. B): 139–144, 1987

    PubMed  Google Scholar 

  • Johnson JO, Hand WL, Francis JB, King-Thompson N, Corwin RW. Antibiotic uptake by alveolar macrophages. Journal of Laboratory and Clinical Medicine 95: 429–439, 1980

    PubMed  CAS  Google Scholar 

  • Kees F, Grobecker H, Fourtillan JB, Tremblay D, Saint-Salvi B. Comparative pharmacokinetics of single dose roxithromycin (150mg) versus erythromycin stearate (500mg) in healthy volunteers. British Journal of Clinical Practice 42(Suppl. 55): 51, 1988

    Google Scholar 

  • Kirst HA, Sides GD, New directions for macrolide antibiotics: pharmacokinetics and clinical efficacy. Antimicrobial Agents and Chemotherapy 33: 1419–1422, 1989

    Article  PubMed  CAS  Google Scholar 

  • Labro MT, Amit N, Babin-Chevaye C, Hakim J. Synergy between Ru 28965 (roxithromycin) and human neutrophils for bactericidal activity in vitro. Antimicrobial Agents and Chemotherapy 30: 137–142, 1986

    Article  PubMed  CAS  Google Scholar 

  • Martin JR, Johnson P, Miller MF. Uptake, accumulation and egress of erythromycin by tissue culture cells of human origin. Antimicrobial Agents and Chemotherapy 27: 314–319, 1985

    Article  PubMed  CAS  Google Scholar 

  • Modai J. The clinical use of macrolides. Journal of Antimicrobial Chemotherapy 22(Suppl. B): 145–153, 1988

    PubMed  Google Scholar 

  • Modai J. Empiric therapy of severe infections in adults. American Journal of Medicine 88(Suppl. 4A): 125–175, 1990

    Google Scholar 

  • Periti P, Mazzei T, Mini E, Novelli A. Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various patho-physiological states (Part II). Clinical Pharmacokinetics 16: 261–282, 1989

    Article  PubMed  CAS  Google Scholar 

  • Pocidalo J-J. Use of fluoroquinolones for intracellular pathogens. Reviews of Infectious Disease 11(Suppl. 5): S979–S984, 1989

    Article  CAS  Google Scholar 

  • Pocidalo J-J, Albert F, Desnottes JF, Kernbaum S. Intraphagocytic penetration of macrolides: in-vivo comparison of erythromycin and spiramycin. Journal of Antimicrobial Chemotherapy 16(Suppl. A): 167–173, 1985

    PubMed  CAS  Google Scholar 

  • Prieto Prieto J, Minguez F, Ortega P, Corrales I, Ledesma V. Comparative study of the effects of roxithromycin and other macrolides on polymorphonuclear white cells in vitro. British Journal of Clinical Practice 42(Suppl. 55): 38–39, 1988

    Google Scholar 

  • Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrobial Agents and Chemotherapy 21: 373–380, 1982

    Article  PubMed  CAS  Google Scholar 

  • Raghoeber M, Lindeyer E, van den Berg W, van Ginneken CAM. On the mechanisms of association of the macrolide antibiotic erythromycin with isolated human polymorphonuclear leucocytes. Biochemical Pharmacology 37: 3221–3227, 1988

    Article  Google Scholar 

  • Research Committee of the British Thoracic Society and the Public Health Laboratory Service. Community-acquired pneumonia in adults in British hospitals in 1982–1983: a survey of aetiology, mortality, prognostic factors and outcome. Quarterly Journal of Medicine 239: 195–200, 1987

    Google Scholar 

  • Schwab JC, Mandell GL. The importance of penetration of antimicrobial agents into cells. Infectious Disease Clinics of North America 3: 461–467, 1989

    PubMed  CAS  Google Scholar 

  • Segre G, Bianchi E, Zanolo G, Bartucci F, Sassella D. Influence of food on the bioavailability of roxithromycin versus erythromycin stearate. British Journal of Clinical Practice 42(Suppl. 55): 55–57, 1988

    Google Scholar 

  • Valcke Y, Pauwels R, Van Der Straeten M. Pharmacokinetics of antibiotics in the lungs. European Respiratory Journal 3: 715–722, 1990

    PubMed  CAS  Google Scholar 

  • Yokoto T, Bhattacharya I. Synergy of bactericidal effect between roxithromycin and human leucocytes against S. aureus. British Journal of Clinical Practice 42(Suppl. 55): 40–42, 1988

    Google Scholar 

  • Young RA, Gonzales JP, Sorkin EM. Roxithromycin: a review of its antibacterial activity, pharmacokinetic properties and clinical efficacy. Drugs 37: 8–41, 1989

    Article  PubMed  CAS  Google Scholar 

  • Zini R, Fournet MP, Barre J, Tremblay D, Tillement JP. In vitro study of roxithromycin binding to serum proteins and erythrocytes in humans. British Journal of Clinical Practice 42(Suppl. 55): 54, 1988

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Infectious Diseases, University of Guadalajara, Jalisco, Mexico

    Eduardo Rodríguez-Noriega

Authors
  1. Eduardo Rodríguez-Noriega
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rodríguez-Noriega, E. Intracellular Infections of the Respiratory Tract. Drug Invest 3 (Suppl 3), 3–6 (1991). https://doi.org/10.1007/BF03258327

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03258327

Keywords

Search

Navigation